Skip to main content

Table 1 Characteristics of T4 NPC patients with intracranial extension who were treated with IMRT plus chemotherapy

From: Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy

Characteristic No. of patients (%)
Age (years)
 Median (range) 46 (21–65)
Gender
 Male 33 (80.5)
 Female 8 (19.5)
Histology
 WHO type II 1 (2.4)
 WHO type III 40 (97.6)
KPS
 70 5 (12.2)
 80 27 (65.8)
 90 9 (22.0)
N category
 N0 2 (4.9)
 N1 23 (56.1)
 N2 11 (26.8)
 N3 5 (12.2)
Stage
 IVA 36 (87.8)
 IVB 5 (12.2)
Completion of chemotherapy
 Induction (2 cycles) 41 (100)
 Adjuvant (2 cycles) 26 (63.4)
 Adjuvant (1 cycle) 7 (17.1)
 Adjuvant (0 cycles) 8 (19.5)
  1. NPC nasopharyngeal carcinoma, IMRT intensity-modulated radiotherapy, WHO World Health Organization, KPS Karnofsky performance status